Literature DB >> 16446121

Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports.

Nikolas Hitiris1, Jeannette A Barrett, Martin J Brodie.   

Abstract

Sexual dysfunction has been reported in both men and women with epilepsy. Associated factors are diverse but include, among others, antiepileptic drugs. We present the cases of 5 men who reported mild to moderate erectile dysfunction or impotence for the first time when treated with the new antiepileptic drug pregabalin as add-on therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446121     DOI: 10.1016/j.yebeh.2005.12.001

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  6 in total

1.  Taking the stress out of treating erectile dysfunction.

Authors:  Andries J Muller; Loren Regier; Brent Jensen
Journal:  Can Fam Physician       Date:  2010-09       Impact factor: 3.275

Review 2.  Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

3.  Molecular and hormonal changes caused by long-term use of high dose pregabalin on testicular tissue: the role of p38 MAPK, oxidative stress and apoptosis.

Authors:  Sarah Hamed N Taha; Hala Saied Zaghloul; Abla Abd El Rahman Ali; Laila Ahmed Rashed; Rania Mohamed Sabry; Iman Fawzy Gaballah
Journal:  Mol Biol Rep       Date:  2020-10-13       Impact factor: 2.316

Review 4.  [Which antiepileptic drug for men with epilepsy? A critical epileptological and andrological review].

Authors:  J Bauer; D Klingmüller
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

Review 5.  The relationship between epilepsy and sexual dysfunction: a review of the literature.

Authors:  Muhammad Atif; Muhammad Rehan Sarwar; Shane Scahill
Journal:  Springerplus       Date:  2016-12-02

6.  Pregabalin for the management of partial epilepsy.

Authors:  Philippe Ryvlin; Emilio Perucca; Sylvain Rheims
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.